Practice guideline on ovarian tissue cryopreservation and transplantation in the prevention and treatment of iatrogenic premature ovarian insufficiency

Ruan，Xiangyan1,2; Xu，Che1,3; Huang，Hefeng4; Xu，Binghe5; Du，Juan1; Cheng，Jiaojiao1; Jin，Fengyu1; Gu，Muqing1; Kong，Weimin1; Yin，Chenghong1; Wu，Yurui6; Tian，Qinjie7; Cao，Yunxia8; Wu，Ruifang9; Xu，Liangzhi10; Jin，Jing1; Li，Yanglu1; Dai，Yinmei1; Ju，Rui1; Ma，Fei5; Wang，Gang11; Wei，Wei1; Huang，Xiaojun12; Qin，Maoquan13; Lin，Yuan14; Sun，Yuan15; Liu，Rong6; Zhang，Wei16; Li，Xiaodong17; Zou，Lin18; Hao，Min19; Ye，Xiyang20; Wang，Fuling21; Wang，Yue22; Hu，Zhuoying23; Huang，Yanhong24; Zhu，Tianyuan25; Yang，Caihong26; Wang，Jinping27; Yang，Xiaomin28; Ni，Rong29; Wang，Liqun30; Luo，Guangxia31; Min，Aiping32; Zhang，Siyou33; Li，Peiling34; Cheng，Linghui8; Li，Lianfang35; Jin，Quanfang36; Shi，Dongmei37; Li，Yan38; Ren，Fangying39; Cheng，Yanxiang40; Niu，Jumin41; Tian，Ying42; Mueck，Alfred O.1,2

2024-04-01

10.1016/j.maturitas.2024.107922

Maturitas   影响因子和分区

0378-5122

1873-4111

Premature ovarian insufficiency (POI) refers to the decline of ovarian function before the age of 40. POI causes a reduction in or loss of female fertility, accompanied by different degrees of menopausal symptoms, which increases the risk of chronic diseases related to early menopause and seriously affects patients' quality of life and health. It is conservatively estimated that at least one million prepubertal girls and women of reproductive age in China are at risk of iatrogenic POI caused by radiotherapy and chemotherapy every year. With the development of medical technology and the breakthrough of scientific and technological advances, preventing and treating iatrogenic POI have become possible. International and national guidelines consider cryopreserved ovarian tissue transplantation to be the most promising method of preserving the ovarian function and fertility of prepubertal girls and women of reproductive age who cannot delay radiotherapy and chemotherapy. In order to guide the clinical application of ovarian tissue cryopreservation and transplantation technology in China, the Guideline Working Group finally included 14 scientific questions and 18 recommendations through a questionnaire survey, field investigation, and consultation of a large number of Chinese and English literature databases in order to provide a reference for colleagues in clinical practice.

Iatrogenic premature ovarian insufficiency Ovarian function and fertility preservation Ovarian tissue cryopreservation Ovarian tissue transplantation Practice guideline Prevention and treatment

SCI

英语

其他

CLINICAL MEDICINE

2-s2.0-85184757712

Scopus

1.Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing Maternal and Child Health Care Hospital,Beijing,China
2.Department for Women's Health,University Women's Hospital and Research Center for Women's Health,University of Tuebingen,Tuebingen,Germany
3.Fuxing Hospital,Capital Medical University,Beijing,China
4.Ministry of Education Key Laboratory of Reproductive Genetics,Shool of Medicine,Zhejiang University,Hangzhou,China
5.National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China
6.Children's Hospital,Capital Institute of Pediatrics,Beijing,China
7.Peking Union Medical College Hospital,Peking Union Medical College/Chinese Academy of Medical Sciences,Beijing,China
8.The First Affiliated Hospital of Anhui Medical University,Anhui,China
9.Peking University Shenzhen Hospital,Shenzhen,China
10.West China Second University Hospital,Sichuan University,Chengdu,China
11.Sichuan Provincial Maternity and Child Health Care Hospital,Chengdu,China
12.Peking University People's Hospital,Beijing,China
13.National Center for Children's Health,Hematology Center,Beijing Children's Hospital,Capital Medical University,Beijing,China
14.Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics,Fujian Medical University,Fujian,China
15.Beijing Jingdu Children's Hospital,Beijing,China
16.Obstetrics and Gynecology Hospital of Fudan University,Shanghai,China
17.The First Hospital of Hebei Medical University,Hebei,China
18.Affiliated Hospital of Guangdong Medical University,Guangdong,China
19.Second Hospital of Shanxi Medical University,Shanxi,China
20.Shenzhen People's Hospital (The Second Clinical Medical College,Jinan University; The First Affiliated Hospital,Southern University of Science and Technology),Shenzhen,China
21.The Affiliated Hospital of Qingdao University,Qingdao,China
22.Henan Provincial People's Hospital,Zhengzhou,China
23.The First Affiliated Hospital of Chongqing Medical University,Chongqing,China
24.Xi'an International Medical Center Hospital,Xi'an,China
25.Gansu Provincial Maternal and Child-care Hospital/Gansu Province Central Hospital,Lanzhou,China
26.The General Hospital of Ningxia Medical University,Ningxia,China
27.Zibo Maternal And Child Health Hospital,Zibo,China
28.Liuzhou Maternity and Child Healthcare Hospital,Liuzhou,China
29.The Central Hospital of Enshi Tu Jia and Miao Autonomous Prefecture,Enshi,China
30.Jiangxi Maternal and Child Health Hospital,Jiangxi,China
31.The First People's Hospital of Huaihua (Hunan University of Medicine General Hospital),Huaihua,China
32.People's Hospital of Leshan City,Leshan,China
33.The First People's Hospital of Foshan,Foshan,China
34.The Second Affiliated Hospital of Harbin Medical University,Harbin,China
35.Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Huairou Maternal and Child Health Care Hospital,Huairou,China
36.Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai,China
37.Maternal and Child Health Hospital of Yinchuan,Yinchuan,China
38.Luoyang Anhe Hospital,Luoyang,China
39.People's Hospital of Linxi County,Hebei,China
40.Renmin Hospital of Wuhan University,Wuhan,China
41.Shenyang Women's and Children's Hospital,Shenyang,China
42.XiangXi Ninger Obstetrics and Gynecology Hospital,Xiangxi,China

Ruan，Xiangyan,Xu，Che,Huang，Hefeng,et al. Practice guideline on ovarian tissue cryopreservation and transplantation in the prevention and treatment of iatrogenic premature ovarian insufficiency[J]. Maturitas,2024,182.

Ruan，Xiangyan.,Xu，Che.,Huang，Hefeng.,Xu，Binghe.,Du，Juan.,...&Mueck，Alfred O..(2024).Practice guideline on ovarian tissue cryopreservation and transplantation in the prevention and treatment of iatrogenic premature ovarian insufficiency.Maturitas,182.

Ruan，Xiangyan,et al."Practice guideline on ovarian tissue cryopreservation and transplantation in the prevention and treatment of iatrogenic premature ovarian insufficiency".Maturitas 182(2024).